StageZero Life Sciences (SZLSF) Short Interest Ratio & Short Volume $0.0017 -0.02 (-93.03%) (As of 11/20/2024 12:34 PM ET) Add Compare Share Share Short Interest Stock AnalysisChartFinancialsSEC FilingsShort Interest StageZero Life Sciences Short Interest DataStageZero Life Sciences (SZLSF) has a short interest of 2,400 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 398 shares to cover all short positions.Current Short Interest2,400 sharesPrevious Short Interest2,400 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$190.68Short Interest Ratio0.4 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares123,530,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume25,000 sharesAverage Trading Volume398 sharesToday's Volume Vs. Average6,287% Short Selling StageZero Life Sciences? Sign up to receive the latest short interest report for StageZero Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSZLSF Short Interest Over TimeSZLSF Days to Cover Over TimeSZLSF Percentage of Float Shorted Over Time Ad Brownstone ResearchBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.I believe we are about to do it again with this new AI project called Stargate StageZero Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20242,400 shares $190.68 No ChangeN/A0.4 $0.08 10/15/20242,400 shares $219.84 No ChangeN/A1.5 $0.09 9/30/20242,400 shares $96.00 -76.9%N/A0.2 $0.04 9/15/202410,400 shares $832.00 -22.4%N/A8.7 $0.08 8/31/202413,400 shares $670.00 -33.3%N/A1.2 $0.05 8/15/202420,100 shares $804.00 +30.5%N/A2.2 $0.04 Get the Latest News and Ratings for SZLSF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for StageZero Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 7/31/202415,400 shares $320.32 No ChangeN/A6.4 $0.02 7/15/202415,400 shares $231.00 No ChangeN/A22 $0.02 6/30/202415,400 shares $23.10 -5.5%N/A15.4 $0.00 6/15/202416,300 shares $195.60 No ChangeN/A7.1 $0.01 5/31/202416,300 shares $652.00 No ChangeN/A40.8 $0.04 5/15/202416,300 shares $208.64 -31.8%N/A9.1 $0.01 4/30/202423,900 shares $956.00 +3.9%N/A7.5 $0.04 4/15/202423,000 shares $662.40 -1.3%N/A0.1 $0.03 3/31/202423,300 shares $816.67 No ChangeN/A1.4 $0.04 3/15/202423,300 shares $629.10 -0.9%N/A8 $0.03 2/29/202423,500 shares $728.50 -1.3%N/A16.8 $0.03 2/15/202423,800 shares $716.38 -19.1%N/A9.2 $0.03 1/15/202429,400 shares $961.38 +10.1%N/A6.7 $0.03 12/31/202326,700 shares $784.98 -2.9%N/A3.3 $0.03 12/15/202327,500 shares $863.50 -6.8%N/A8.3 $0.03 11/30/202329,500 shares $976.45 +555.6%N/A1.5 $0.03 11/15/20234,500 shares $151.65 -39.2%N/A5.6 $0.03 10/31/20237,400 shares $271.58 +208.3%N/A3.4 $0.04 10/15/20232,400 shares $86.64 No ChangeN/A0.3 $0.04 9/30/20232,400 shares $96.96 No ChangeN/A0.5 $0.04 9/15/20232,400 shares $103.80 No ChangeN/A0 $0.04 8/31/20232,400 shares $103.80 No ChangeN/A4.3 $0.04 8/15/20232,400 shares $118.80 -46.7%N/A3.4 $0.05 7/31/20234,500 shares $212.85 No ChangeN/A1.7 $0.05 7/15/20234,500 shares $203.85 +87.5%N/A9 $0.05 6/30/20232,400 shares $110.76 No ChangeN/A8 $0.05 6/15/20232,400 shares $112.08 No ChangeN/A1.8 $0.05 5/31/20232,400 shares $102.86 -73.3%N/A0.6 $0.04 5/15/20239,000 shares $569.70 No ChangeN/A22.5 $0.06 4/30/20239,000 shares $569.70 No ChangeN/A6 $0.06 4/15/20239,000 shares $544.50 -69.9%N/A1.1 $0.06 3/31/202329,900 shares $1,964.43 -0.3%N/A149.5 $0.07 3/15/202330,000 shares $2,505.00 +934.5%N/A3.3 $0.08 2/28/20232,900 shares $295.51 -14.7%N/A0.1 $0.10Bill Gates’s Next Big AI Bet: Stargate (Ad)In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.I believe we are about to do it again with this new AI project called Stargate 2/15/20233,400 shares $199.92 -46.9%N/A0.3 $0.06 1/31/20236,400 shares $327.04 +45.5%N/A1.5 $0.05 1/15/20234,400 shares $220.66 No ChangeN/A8.8 $0.05 12/30/20224,400 shares $194.92 No ChangeN/A0.5 $0.04 12/15/20224,400 shares $234.08 -31.3%N/A1.2 $0.05 11/30/20226,400 shares $338.56 -13.5%N/A1.5 $0.05 11/15/20227,400 shares $439.82 -11.9%N/A1.3 $0.06 10/31/20228,400 shares $479.98 -5.6%N/A0 $0.06 10/15/20228,900 shares $508.55 No ChangeN/A89 $0.06 9/30/20228,900 shares $508.55 -5.3%N/A1.3 $0.06 9/15/20229,400 shares $589.38 No ChangeN/A18.8 $0.06 8/31/20229,400 shares $648.60 -9.6%N/A7.8 $0.07 8/15/202210,400 shares $676.00 -35.4%N/A0.6 $0.07 7/31/202216,100 shares $1,006.25 +0.6%N/A8.5 $0.06 7/15/202216,000 shares $968.00 -60.3%N/A3.3 $0.06 6/30/202240,300 shares $2,579.20 -32.0%N/A13.4 $0.06 6/15/202259,300 shares $3,670.67 -1.7%N/A8.7 $0.06 5/31/202260,300 shares $4,287.33 No ChangeN/A19.5 $0.07 5/15/202260,300 shares $4,727.52 +238.8%N/A50.3 $0.08 4/30/202217,800 shares $1,329.66 +44.7%N/A0.8 $0.07 4/15/202212,300 shares $1,060.26 -3.9%N/A0.4 $0.09 3/31/202212,800 shares $1,816.32 -69.6%N/A2 $0.14 3/15/202242,100 shares $6,900.19 -43.9%N/A3.1 $0.16 2/28/202275,100 shares $11,640.50 -16.5%N/A46.9 $0.16 2/15/202289,900 shares $17,458.58 -0.3%N/A17.6 $0.19 1/31/202290,200 shares $16,957.60 +14.6%N/A10 $0.19 1/15/202278,700 shares $18,876.20 -0.6%N/A5.2 $0.24 12/31/202179,200 shares $18,239.76 -3.1%N/A9.5 $0.23 12/15/202181,700 shares $18,791.00 +181.7%N/A8.8 $0.23 11/30/202129,000 shares $7,577.70 +205.3%N/A0.5 $0.26 11/15/20219,500 shares $2,375.00 -81.5%N/A1 $0.25 10/29/202151,300 shares $14,364.00 +5.1%N/A0.5 $0.28 10/15/202148,800 shares $14,640.00 No ChangeN/A13.6 $0.30 9/30/202148,800 shares $14,654.64 -27.4%N/A5.4 $0.30 9/15/202167,200 shares $21,524.16 -34.1%N/A12.2 $0.32 8/31/2021101,900 shares $32,852.56 -29.7%N/A15.7 $0.32 8/13/2021144,900 shares $51,120.72 No ChangeN/A20.4 $0.35 7/30/2021144,900 shares $51,135.21 +1.1%N/A27.9 $0.35 7/15/2021143,400 shares $0.00 No ChangeN/A22.4 $0.00 SZLSF Short Interest - Frequently Asked Questions What is StageZero Life Sciences' current short interest? Short interest is the volume of StageZero Life Sciences shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 2,400 shares of SZLSF short. Learn More on StageZero Life Sciences' current short interest. How does StageZero Life Sciences' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to StageZero Life Sciences: Aspira Women's Health Inc. (4.86%), Trinity Biotech plc (0.86%), Virax Biolabs Group Limited (11.02%), Cardio Diagnostics Holdings, Inc. (7.65%), Biomerica, Inc. (3.34%), MyMD Pharmaceuticals, Inc. (11.82%), IDEXX Laboratories, Inc. (2.57%), Lantheus Holdings, Inc. (6.03%), Neogen Co. (9.08%), QuidelOrtho Co. (6.17%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short StageZero Life Sciences stock? Short selling SZLSF is an investing strategy that aims to generate trading profit from StageZero Life Sciences as its price is falling. SZLSF shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against StageZero Life Sciences? A short squeeze for StageZero Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SZLSF, which in turn drives the price of the stock up even further. How often is StageZero Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SZLSF, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies AWH Short Squeeze TRIB Short Squeeze VRAX Short Squeeze CDIO Short Squeeze BMRA Short Squeeze MYMD Short Squeeze BGMD Short Squeeze IPSEY Short Squeeze IDXX Short Squeeze LNTH Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:SZLSF) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding StageZero Life Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share StageZero Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
